
    
      The study has 3 parts. Part A is a single ascending dose (SAD) study in healthy volunteers.
      Part B is a single ascending dose study (SAD) in patients with HBV infection. Part C is a
      multiple ascending dose study (MAD) in patients with HBV infection.
    
  